See What's Inside
Read this FREE issue now
For healthcare professionals only

You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View

See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.

Learn More About the Professional Subscription

Free Diabetes Health e-Newsletter
Latest
Popular
Top Rated

New Diabetes Cure Research Article Archives

May 2011

N.J. Hospital Teams With Ricordi to Find Cure for Type 1

New Jersey's Hackensack University Medical Center has announced that it will partner with Dr. Camillo Ricordi to test a surgical procedure that could hold the key to a cure for type 1 diabetes.

comments 11 comments - Posted May 18, 2011

March 2011

Pre-Diabetes Glossary

This List defines terms that people with prediabetes commonly encounter as they learn more about the condition.

comments 2 comments - Posted Mar 29, 2011

Should States Let Inmates Donate Organs?

If a prisoner on death row wants to donate his organs, should he be allowed to do it?

comments 19 comments - Posted Mar 18, 2011

February 2011

Type 1 Diabetes Associated With Common Cold Virus

It's generally thought that a genetic predisposition to type 1 diabetes is not enough to develop the disease, but that an environmental trigger is required to activate it. Researchers are not sure what that environmental trigger is, but enteroviruses have been under suspicion for quite a while. Enteroviruses are the second leading cause of viral colds in children.

comments 1 comment - Posted Feb 8, 2011

December 2010

Stem cells used to make pancreas, gut cells

(Reuters) - Stem cells can be transformed into the pancreatic cells needed to treat diabetes and into complex layers of intestinal tissue, scientists demonstrated in two experiments reported on Sunday.

comments 6 comments - Posted Dec 13, 2010

A Gift of Love. A Gift of Hope...For the Holidays.

Celebrate the season with an eCard and help support the Diabetes Research Institute! Send your family, friends or business colleagues A Gift of Love...A Gift of Hope. They will feel special knowing you are supporting research to find a cure for diabetes.

comments 0 comments - Posted Dec 3, 2010

September 2010

UCSF Diabetes Symposium Marks Decade of Research Advances

Diabetes research is on the cusp of new advances in treatment options and in understanding the underlying causes of both type 1 and type 2 diabetes. Among those are potential treatments using stem cells to regenerate a patient's ability to produce insulin, as well as upcoming clinical trials of a vaccine that potentially could prevent type 1 diabetes.

comments 2 comments - Posted Sep 27, 2010

August 2010

MannKind Corporation Providing AFREZZA to JDRF for Artificial Pancreas Project

MannKind Corporation announced that the company will supply its novel, ultra rapid acting insulin AFREZZATM (insulin human [rDNA origin]) for use in a study being conducted by the Juvenile Diabetes Research Foundation (JDRF) as part of its Artificial Pancreas Project. The planned two-year study in patients with type 1 diabetes will leverage the unique rapid action of AFREZZA for use in a closed-loop blood sugar monitoring and insulin delivery system, termed the "artificial pancreas" by the JDRF. The study will be managed in conjunction with the Sansum Diabetes Research Institute and the University of California, Santa Barbara.

comments 0 comments - Posted Aug 29, 2010

June 2010

Double Transplantation Treatment for Type 1 Diabetes

City of Hope researchers have found that bone marrow transplantation with islet cell transplantation shows promise as a treatment for late-stage type 1 diabetes. This combination may enable patients to make their own insulin again.  Results from laboratory research led by Defu Zeng, MD, associate professor in the departments of Diabetes Research and Hematology & Hematopoietic Cell Transplantation at City of Hope, were published online this month in the journal Diabetes.

comments 0 comments - Posted Jun 25, 2010

May 2010

Stem Cell Treatment for Type 1 Diabetes

Osiris Therapeutics announced that it has been granted Orphan Drug designation from the U.S. Food and Drug Administration (FDA) for Prochymal as a treatment for type 1 diabetes mellitus. The FDA instituted the Orphan Drug Act to promote the development of treatments for underserved patient populations. To be eligible for Orphan Drug designation, the treatment must target a disease that affects fewer than 200,000 new patients per year in the United States.

comments 0 comments - Posted May 7, 2010

March 2010

The Story of GAD

You may not have heard of GAD, but it's a hot topic in the world of type 1 diabetes research. GAD, which stands for glutamic acid decarboxylase, is an enzyme in the brain and the pancreas that plays several roles in the body. As an enzyme, it converts the excitatory amino acid glutamate into the inhibitory neurotransmitter GABA, which nerve cells use to communicate.  But it also has a less helpful role, as an autoantigen (an element of self that provokes the generation of antibodies) in autoimmune diabetes.

comments 4 comments - Posted Mar 23, 2010

December 2009

Airman Injured in Afghanistan Receives Unprecedented Islet Cell Transplant

WASHINGTON, Dec. 15 /PRNewswire-USNewswire/ -- A 21-year old Airman severely wounded in Afghanistan is recovering at Walter Reed Army Medical Center after several surgeries and an unprecedented transplant.

comments 2 comments - Posted Dec 17, 2009

March 2009

At Last! Restrictions on Stem Cell Research Lifted

"Medical miracles do not happen simply by accident," said President Obama, as he signed an executive order lifting the ban on federally funded embryonic stem cell research. The Juvenile Diabetes Research Foundation (JDRF) is celebrating President Obama's new policy. They recently released this statement by Mary Tyler Moore, the International Chairman of the JDRF: 

comments 12 comments - Posted Mar 17, 2009

December 2008

Non-Beta Pancreatic Cells Can Be Stimulated to Become New Beta Cells
Non-Beta Pancreatic Cells Can Be Stimulated to Become New Beta Cells

Non-beta "progenitor" cells in the pancreas can be stimulated to turn into beta cells even after birth or autoimmune injury to the pancreas, say researchers at Joslin Diabetes Center in Boston, an affiliate of Harvard Medical School.

comments 3 comments - Posted Dec 2, 2008

October 2008

Anti-Inflammatory Protein from the Liver Appears to Cure Type 1 in Mice
Anti-Inflammatory Protein from the Liver Appears to Cure Type 1 in Mice

Diabetes Health has always been ambivalent when it comes to reporting diabetes research that involves mice. For one thing, although the critters are mammals, it's a stretch to say that what happens in a mouse can be duplicated in a human.

comments 6 comments - Posted Oct 20, 2008

July 2008

Rogue Enzymes Linked to Hypertension and Diabetes
Rogue Enzymes Linked to Hypertension and Diabetes

Molecular malfunction may explain the development of high blood pressure, diabetes and immune problems, says a new research report.

comments 9 comments - Posted Jul 3, 2008

June 2008

Interim Study Shows That Intestinal Barrier Produces Weight Loss and Type 2 Remission
Interim Study Shows That Intestinal Barrier Produces Weight Loss and Type 2 Remission

An impermeable liner inserted non-surgically into a portion of the small intestine produces rapid weight loss and remission of type 2 diabetes, according to a Montana endocrinologist.

comments 0 comments - Posted Jun 26, 2008

Study by 24 Doctors and Researchers Lobs Rebuttal At the ADA and EASD for Their Stance on Low-Carb
Study by 24 Doctors and Researchers Lobs Rebuttal At the ADA and EASD for Their Stance on Low-Carb

Twenty-four diabetes doctors and researchers from the United States, Canada, the United Kingdom, Finland, Sweden and Portugal have published a study criticizing the American Diabetes Association (ADA) assertion that diabetics should consume no fewer than 130 mg of carbohydrates daily and the European Association for the Study of Diabetes (EASD) statement that low-carb diets are “not justified.”

comments 28 comments - Posted Jun 26, 2008

This Week's Diabetes Research Highlights
This Week's Diabetes Research Highlights

Tekturna Reduces Kidney Disease Indicator

The blood pressure medicine Tekturna (aliskiren) may have a beneficial side effect for people with type 2 diabetes and high blood pressure who are at risk of kidney disease. According to a recent article in The New England Journal of Medicine, the drug reduces proteinuria, a key indicator of kidney disease, by 20 percent in patients with type 2 diabetes.

comments 2 comments - Posted Jun 26, 2008

©1991-2014 Diabetes Health | Home | Privacy | Press | Advertising | Help | Contact Us | Donate | Sitemap

Diabetes Health Medical Disclaimer

The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.